Related Experiment Video
Updated: Jun 2, 2026
11:40
Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Polycomb group proteins in hematopoietic stem cell aging and malignancies
Karin Klauke1,2, Gerald de Haan3,4
1Department of Cell Biology, Section of Stem Cell Biology, University Medical Center Groningen, University of Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
International Journal of Hematology
|April 28, 2011
Summary
Polycomb group (PcG) proteins are crucial for maintaining healthy hematopoietic stem cells (HSCs) and preventing age-related changes and leukemia. Their proper function balances HSC aging with cancer risk.
Area of Science:
- Hematology
- Epigenetics
- Stem Cell Biology
Background:
- Hematopoietic stem cells (HSCs) require protection of their transcriptional network for lifelong health.
- Epigenetic alterations in HSCs contribute to aging and increase leukemia risk.
- Polycomb group (PcG) proteins are critical epigenetic regulators in HSCs and are implicated in hematopoietic malignancies.
Purpose of the Study:
- To review the role of PcG proteins in HSC aging and cancer development.
- To explore the hypothesis that PcG proteins balance HSC aging with cancer risk.
Main Methods:
- This is a review article, not an experimental study.
- Literature review and theoretical speculation on the function of PcG proteins.
Main Results:
- PcG proteins are key regulators of HSC fate, senescence, apoptosis, and DNA repair.
- Misregulation of PcG proteins is linked to hematopoietic malignancies.
- Disturbances in PcG function impact crucial cellular processes.
Conclusions:
- PcG proteins play a vital role in maintaining HSC health and preventing malignant transformation.
- The balance maintained by PcG proteins is critical for preventing both premature aging and cancer in HSCs.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...